CompletedNot Applicable

Upper Extremity Robotic Rehabilitation in Patients With Hemiplegia

Turkey (Türkiye)37 participantsStarted 2016-04-14

Plain-language summary

Comparison of Upper Extremity Robotic Rehabilitation Efficiency with Conventional Rehabilitation in Patients with Hemiplegia after Cerebrovascular Event

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having a single stroke * Being an adult * Having a duration of 4 to 30 months after stroke * A score greater than 16 in mini-mental test * Upper extremity Brunnstrom stage 2 or higher * Being a fluent speaker in Turkish. Exclusion Criteria: * Severe apraxia * Skin ulcers * Multiple cerebrovascular events * Severe decompensated diseases (cardiopulmonary, neurological, orthopedic and psychiatric etc), cardiac pacemakers, severe neuropsychological impairment, * Neglect syndrome * Spasticity greater than 3 in Modified Ashworth Scale * Severe joint contractures * Botulinum toxin-A injection in their upper extremity and dose change in drugs for spasticity in the last 3 months.

What they're measuring

Change from baseline hand grip strength at 4th week.

Timeframe: Up to 4 weeks

Change from baseline hand functions (Minnesota manuel dexterity test) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline hand functions (Purdue peg board) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline spasticity (Modified Ashworth Scale (MAS)) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline neurophysiological development (Brunnstrom stage) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline motor function (Fugl Meyer Assessment (FMA)) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline general function (Functional Independance Measure (FIM)) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline quality of life (Stroke Specific Quality of Life Scale (SS-QOL)) at 4th week.

Trial details

NCT IDNCT04393480

SponsorSahel Taravati, M.D.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04-14

View on ClinicalTrials.gov More Hemiplegia and/or Hemiparesis Following Stroke trials

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change from baseline hand grip strength at 4th week.

Timeframe: Up to 4 weeks

Change from baseline hand functions (Minnesota manuel dexterity test) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline hand functions (Purdue peg board) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline spasticity (Modified Ashworth Scale (MAS)) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline neurophysiological development (Brunnstrom stage) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline motor function (Fugl Meyer Assessment (FMA)) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline general function (Functional Independance Measure (FIM)) at 4th week.

Timeframe: Up to 4 weeks

Change from baseline quality of life (Stroke Specific Quality of Life Scale (SS-QOL)) at 4th week.